# BioLife Solutions, Inc. (BLFS) FY2026 Q2 Balance Sheet

- Company: BioLife Solutions, Inc. (BLFS)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001628280-26-054355
- Page: https://plicit.ai/financials/blfs/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/blfs-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 447,494,000 US dollars
- **Current assets**: 135,198,000 US dollars
- **Non-current assets**: 312,296,000 US dollars
- **Liabilities**: 27,491,000 US dollars
- **Current liabilities**: 13,947,000 US dollars
- **Non-current liabilities**: 13,544,000 US dollars
- **Equity**: 420,003,000 US dollars
- **Available-for-sale securities, current portion**: 58,419,000 US dollars
- **Inventories**: 35,591,000 US dollars
- **Cash and cash equivalents**: 23,997,000 US dollars
- **Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively**: 10,652,000 US dollars
- **Prepaid expenses and other current assets**: 6,539,000 US dollars
- **Goodwill**: 208,587,000 US dollars
- **Deferred tax assets, net**: 42,233,000 US dollars
- **Available-for-sale securities, long-term**: 30,654,000 US dollars
- **Property and equipment, net**: 15,235,000 US dollars
- **Operating lease right-of-use assets, net**: 8,644,000 US dollars
- **Intangible assets, net**: 3,654,000 US dollars
- **Other assets**: 3,289,000 US dollars
- **Accrued expenses and other current liabilities**: 6,798,000 US dollars
- **Lease liabilities, operating, current portion**: 2,593,000 US dollars
- **Accounts payable**: 2,482,000 US dollars
- **Sales taxes payable**: 2,074,000 US dollars
- **Debt, current portion**: 0 US dollars
- **Lease liabilities, operating, long-term**: 13,145,000 US dollars
- **Other long-term liabilities**: 399,000 US dollars
- **Deferred tax liabilities**: 0 US dollars
- **Additional paid-in capital**: 713,571,000 US dollars
- **Common stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 2025**: 49,000 US dollars
- **Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025**: 0 US dollars
- **Accumulated deficit**: negative 293,406,000 US dollars
- **Accumulated other comprehensive (loss) income, net of tax**: negative 211,000 US dollars
- **Gross equity (calculated)**: 713,620,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.